Clinical trials in Guetersloh

Innovative clinical trials focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer treatments. Studies evaluate targeted therapies including abemaciclib and CDK4/6 inhibitors.

• Early-stage breast cancer treatments
• Metastatic breast cancer therapies
• Endocrine therapy combinations

Research aims to improve disease-free survival rates and establish more effective treatment protocols.

Comprehensive research into non-small cell lung cancer (NSCLC) treatments, examining novel drug combinations and immunotherapy approaches with durvalumab and other agents.

• Advanced stage NSCLC treatments
• Immunotherapy combinations
• Targeted therapeutic approaches

Focus on improving survival outcomes for patients with locally advanced or metastatic disease.

Trials investigating treatments for gastric and gastroesophageal junction adenocarcinomas, including studies with ramucirumab and bemarituzumab for advanced disease.

• Advanced stomach cancer therapies
• Second-line treatment options
• Targeted biological therapies

Research focuses on improving outcomes for patients who have failed first-line treatments.